165 related articles for article (PubMed ID: 16944044)
1. Two years of growth hormone replacement therapy in a group of patients with Sheehan's syndrome.
Soares DV; Spina LD; de Lima Oliveira Brasil RR; Lobo PM; Salles E; Coeli CM; Conceição FL; Vaisman M
Pituitary; 2006; 9(2):127-35. PubMed ID: 16944044
[TBL] [Abstract][Full Text] [Related]
2. Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement.
Soares DV; Spina LD; de Lima Oliveira Brasil RR; da Silva EM; Lobo PM; Salles E; Coeli CM; Conceição FL; Vaisman M
Metabolism; 2005 Mar; 54(3):321-9. PubMed ID: 15736109
[TBL] [Abstract][Full Text] [Related]
3. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
4. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency.
Colao A; Di Somma C; Filippella M; Rota F; Pivonello R; Orio F; Vitale G; Lombardi G
Clin Endocrinol (Oxf); 2004 Sep; 61(3):360-6. PubMed ID: 15355453
[TBL] [Abstract][Full Text] [Related]
6. Glucose metabolism and visceral fat in GH deficient adults: two years of GH-replacement.
Spina LD; Soares DV; Brasil RR; Lobo PM; Lúcia Conceição F; Vaisman M
Pituitary; 2004; 7(3):123-129. PubMed ID: 16328562
[TBL] [Abstract][Full Text] [Related]
7. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.
Kelestimur F; Jonsson P; Molvalilar S; Gomez JM; Auernhammer CJ; Colak R; Koltowska-Häggström M; Goth MI
Eur J Endocrinol; 2005 Apr; 152(4):581-7. PubMed ID: 15817914
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency.
Colao A; Di Somma C; Rota F; Pivonello R; Savanelli MC; Spiezia S; Lombardi G
J Clin Endocrinol Metab; 2005 Apr; 90(4):2056-62. PubMed ID: 15671089
[TBL] [Abstract][Full Text] [Related]
9. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.
Chrisoulidou A; Beshyah SA; Rutherford O; Spinks TJ; Mayet J; Kyd P; Anyaoku V; Haida A; Ariff B; Murphy M; Thomas E; Robinson S; Foale R; Johnston DG
J Clin Endocrinol Metab; 2000 Oct; 85(10):3762-9. PubMed ID: 11061536
[TBL] [Abstract][Full Text] [Related]
10. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency.
Colao A; Di Somma C; Spiezia S; Savastano S; Rota F; Savanelli MC; Lombardi G
J Clin Endocrinol Metab; 2008 Sep; 93(9):3416-24. PubMed ID: 18593773
[TBL] [Abstract][Full Text] [Related]
12. Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.
Gómez JM; Sahún M; Vila R; Domènech P; Catalina P; Soler J; Badimón L
Clin Endocrinol (Oxf); 2006 Jun; 64(6):632-9. PubMed ID: 16712664
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance, metabolic syndrome and chronic low grade inflammation in Sheehan's syndrome on standard replacement therapy: a case control study.
Bhat MA; Laway BA; Shah ZA; Wani AI; Mubarik I
Pituitary; 2015 Jun; 18(3):312-8. PubMed ID: 24879499
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
Monson JP; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Stâhl E; Thorén M; Westberg B; Wilton P; Wüster C
Clin Endocrinol (Oxf); 2000 Sep; 53(3):281-9. PubMed ID: 10971444
[TBL] [Abstract][Full Text] [Related]
15. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
O'Neal DN; Hew FL; Best JD; Alford F
Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
[TBL] [Abstract][Full Text] [Related]
16. Glucose metabolism and visceral fat in GH deficient adults: 1 year of GH replacement.
Spina LD; Soares DV; Brasil RR; da Silva EM; Lobo PM; Conceição FL; Vaisman M
Growth Horm IGF Res; 2004 Feb; 14(1):45-51. PubMed ID: 14700554
[TBL] [Abstract][Full Text] [Related]
17. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy.
Golgeli A; Tanriverdi F; Suer C; Gokce C; Ozesmi C; Bayram F; Kelestimur F
Eur J Endocrinol; 2004 Feb; 150(2):153-9. PubMed ID: 14763913
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.
Wallenfeldt K; Bokemark L; Wikstrand J; Hulthe J; Fagerberg B
Stroke; 2004 Oct; 35(10):2248-52. PubMed ID: 15345795
[TBL] [Abstract][Full Text] [Related]
19. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.
Weaver JU; Monson JP; Noonan K; John WG; Edwards A; Evans KA; Cunningham J
J Clin Endocrinol Metab; 1995 Jan; 80(1):153-9. PubMed ID: 7829604
[TBL] [Abstract][Full Text] [Related]
20. Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.
Oliveira JL; Aguiar-Oliveira MH; D'Oliveira A; Pereira RM; Oliveira CR; Farias CT; Barreto-Filho JA; Anjos-Andrade FD; Marques-Santos C; Nascimento-Junior AC; Alves EO; Oliveira FT; Campos VC; Ximenes R; Blackford A; Parmigiani G; Salvatori R
J Clin Endocrinol Metab; 2007 Dec; 92(12):4664-70. PubMed ID: 17911170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
